PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
NCT ID: NCT01208077
Last Updated: 2015-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
514 participants
OBSERVATIONAL
2010-09-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Non Invasive Hemodynamic Cardiovascular Monitoring to Evaluate Emergency Department Patients
NCT00851214
Acute Heart Failure Study in Patients Admitted to Emergency Department for Dyspnea
NCT02835963
Hemodynamic Monitoring and Fluid Responsiveness in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) - "HemodynamECMOnitoring-VA Study"
NCT06593756
Non-Invasive Shock: Differentiating Shock in the Emergency Department
NCT02164851
Targeting of UnControlled Hypertension in Emergency Department
NCT03749499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The treating ED physicians will be blinded to the hemodynamic monitoring and there will be no modification of the standard care that each patient receives. Hospital charts will be reviewed and patients/family members will be additionally called at 30 days after the hospital visit in order to collect any additional outcome data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute CHF
1. Recurrent or worsening (within 3 days) shortness of breath as the primary presenting ED complaint
2. Initial treating ED physician impression that the worsening dyspnea is most likely caused by decompensated CHF
3. Known history of physician diagnosed CHF
4. Natriuretic peptide (BNP, MR-pro ANP, NT pro BNP) level will be ordered by the treating physician as part of the patient's work up
No interventions assigned to this group
Acute Stroke Syndrome
1. Onset of abnormal neurological symptoms consistent with possible stroke, within the prior 24 hours, as the primary ED complaint
2. Initial treating ED physician impression that the abnormal neurological symptoms/signs are most likely caused by an acute stroke syndrome
3. Non contrast head CT will be ordered by the treating physician as part of the patient's work up
No interventions assigned to this group
Acute Systemic Infection
1. Any combinations of acute (within 3 days) symptoms and signs that the treating ED physician, after initial history and physical examination, attributes to a systemic infection
2. Blood cultures and/or a blood lactate will be ordered by the treating physician as part of the patient's work up
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
* No initiated therapy since arrival to the ED
* Must be enrolled within 4 hours of arrival to the ED
* Recurrent or worsening (within 3 days) shortness of breath as the primary presenting ED complaint
* Initial treating ED physician impression that the worsening dyspnea is most likely caused by decompensated CHF
* Known history of physician diagnosed CHF
* Natriuretic peptide (BNP, MR-pro ANP, NT pro BNP) level will be ordered by the treating physician as part of the patient's work up
* Onset of abnormal neurological symptoms consistent with possible stroke, within the prior 24 hours, as the primary ED complaint
* Initial treating ED physician impression that the abnormal neurological symptoms/signs are most likely caused by an acute stroke syndrome
* Non contrast head CT will be ordered by the treating physician as part of the patient's work up
* Any combinations of acute (within 3 days) symptoms and signs that the treating ED physician, after initial history and physical examination, attributes to a systemic infection
* Blood cultures and/or a blood lactate will be ordered by the treating physician as part of the patient's work up
Exclusion Criteria
* Suspected pregnancy
* Not able to be followed up in 30 days
* Patients with "comfort only" DNR status
* Patients with known STEMI
* Excessive agitation
* Transferred from another treating facility
* Known aortic valve disease
* On continuous IV home infusions (such as milrinone, primacor)
* Known Left Ventricular Assist device (LVAD)
* Known prior enrollment in this study
* In current therapeutic Investigational study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BMEYE BV the Netherlands
UNKNOWN
Edwards Lifesciences
INDUSTRY
Henry Ford Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard M Nowak
Sr, Staff Emergency Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard M Nowak, MD
Role: PRINCIPAL_INVESTIGATOR
Henry Ford Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Detroit Receiving Hospital/Wayne State University
Detroit, Michigan, United States
Henry Ford Hospital
Detroit, Michigan, United States
University LaSapienza Rome Sant'Andrea Hospital
Rome, Rome, Italy
VU University Medical Centre
Amsterdam, Amsterdam, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol: HFH DEM 002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.